Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 591 of 1,261
  1. US 9844656

    Localization of agents at a target site with a composition and an energy source

    The Regents of the University of California · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted
  2. US 9844562

    Polyvalent RNA-nanoparticle compositions

    Northwestern University · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted
  3. US 9844598

    Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

    EnGeneIC Molecular Delivery Pty Ltd · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted
  4. US 9845350

    Monoclonal antibodies that react with the capsule of bacillus anthracis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted
  5. US 9844600

    Injectable thermoresponsive polyelectrolytes

    Northwestern University · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted
  6. US 9844530

    Ophthalmic solutions for glaucoma and conjunctivitis treatment

    AXIM BIOTECHNOLOGIES. INC. · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted
  7. US 9845332

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted
  8. US 9844540

    Combination therapies for treating cancer

    RedHill Biopharma Ltd. · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted
  9. US 9846160

    Ganglioside GD2 as a marker and target on cancer stem cells

    The Board of Regents of the University of Texas System · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted
  10. US 9844569

    Methods of producing enriched populations of tumor reactive T cells from peripheral blood

    The United State of America, as Represented by the Secretary, Department of Health and Human Services · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted
  11. US 2017354716

    Novel Polymeric hGH Prodrugs

    ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S [DK] · Granted Dec 14, 2017 · Expires Dec 9, 2037

    granted
  12. US 9839688

    Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer

    Provectus Pharmatech, Inc. · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  13. US 9839698

    Light-switchable gene expression system

    East China University of Science and Technology · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  14. US 9840557

    Anti-IL-25 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  15. US 9839639

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  16. US 9840499

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  17. US 9840482

    Sulfonamide derivatives and pharmaceutical applications thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  18. US 9840460

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  19. US 9841426

    Intracellular organelle peptide targeted enzyme substrates

    Marker Gene Technologies, Inc · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  20. US 9840559

    Anti-CD83 antibodies and use thereof

    The Regents of the University of California · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  21. US 9840558

    Human antibody specific for interleukin-1alpha

    XBIOTECH INC. · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  22. US 9840583

    Fluorescent polymers and applications thereof

    The Board of Regents of the University of Texas System · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  23. US 9840549

    Fusion polypeptides capable of activating receptors

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  24. US 9840536

    Methods and compositions for the treatment of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.